BioSpace News Archive

Precision Medicine Company adyn Raises $2.5M Seed Funding for Personalized Birth Control Empowers women with personalized birth control recommendations aimed to minimize medication side effects, including blood clots and depression

Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions for which there are limited treatment options, today announced findings of pre-clinical research demonstrating that Ampio’s lead drug candidate, Ampion

CliniComp launched a new brand and a complete health records solution that is perfectly suited to meet the needs of community hospitals and healthcare systems. CliniComp’s new product, ORIGINTM, marks the transition to a complete product offering.

F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing next generation bispecific immunotherapies to transform the lives of patients with cancer, today announced the publication of a new study, conducted by Yale University and F-star, of its second generation STING agonist, SB 11285,

Led by Tiger Global, the financing values Virta at $2 billion and signals a shift in type 2 diabetes care toward long-term disease reversal powered by next-generation telehealth

Nanoscope Therapeutics Inc. , a clinical-stage biotechnology company developing gene therapies for treatment of inherited retinal diseases, today announced an expansion of its Clinical Advisory Board with the appointment of four new members.

Advanced Urology today celebrates the one year anniversary of revolutionary same-day discharge outpatient robotic surgery in their ambulatory surgery centers

The Access to Comprehensive Genomic Profiling Coalition (ACGP) announced today the addition of AstraZeneca, Loxo Oncology at Lilly, and Invitae Corporation (NYSE: NVTA) to its coalition of companies advocating for appropriate coverage of comprehensive genomic profiling (CGP) for patients living with advanced cancer by U.S.

Probo Medical (“Probo”), a leading global provider of medical imaging equipment, parts, repair and service, announced today the acquisition of SonoDepot, Inc. (“SonoDepot”). Terms of the transaction were not disclosed.

Inflammasome Therapeutics ( https://www.inflam.com ), a private company developing therapies for prevalent, degenerative diseases, reported newly published research continues to confirm the potential of the company’s proprietary Kamuvudines, to be an effective treatment for geographic atrophy (GA), a severe and untreatable form of age-related macular degeneration (AMD) that causes 20% of legal blindness in the US.